U S Physical Therapy Inc (USPH) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


U S Physical Therapy Inc  (NYSE: USPH)


U S Physical Therapy Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is U S Physical Therapy Inc's ROA in the second quarter of 2026?
U S Physical Therapy Inc achieved a return on average assets (ROA) of 4.07 % in its second quarter of 2026, which is below U S Physical Therapy Inc's average return on assets, which stands at 8.41%.

ROA fell compared to the first quarter of 2026, despite the net income growth of 82.66% from the first quarter of 2026.

However, within the Healthcare sector 170 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1291, from total ROA ranking in the first quarter of 2026 at 1399.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 4.8 % 6.34 % 17.47 % 28.83 % 28.08 %
Y / Y Net Income Change -15.93 % -39.44 % -26.56 % 80.44 % 51.3 %
Net Income (TTM) in million 50 53 58 61 53
Return On Assets (TTM) 4.07 % 4.35 % 4.86 % 5.34 % 4.95 %
USPH's Total Ranking # 1291 # 1399 # 1162 # 1240 # 1314
Total Assets (TTM) in million 1,236 1,255 1,216 1,196 1,180
Seq. Total Assets Change -1.46 % 3.14 % 1.67 % 1.41 % -0.01 %
Seq. Net Income Change 82.66 % -11.11 % -47.99 % -0.44 % 31.57 %



Return On Assets Company Ranking
Within: No.
Industry # 49
Sector # 171
Overall # 1347

Return On Assets Statistics
High Average Low
18.93 %
8.41 %
3.13 %
(Sep 30 2012)   (Sep 30 2024)





Financial Statements
U S Physical Therapy Inc's Assets $ 1,236 million USPH's Balance sheet
U S Physical Therapy Inc's Income $ 15 million Quarterly USPH's Income Statement
USPH's Income by Division See USPH's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 17.47 % 5.71 % 29.38 % 15.5 % 10.32 %
Total Assets in million 1,216 1,035 979 757 655
Y / Y Net Income Change 27.2 % 22.51 % -14.25 % -25.06 % 10.35 %
Net Income in million 58 46 37 43 58
Annual Return On Assets 4.77 % 4.4 % 3.8 % 5.73 % 8.84 %




Comment on USPH's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 4.77 % compared to prior year, due to annual net income growth of 27.2 % to $58.01 million, while value of U S Physical Therapy Inc's overall assets grew just by 17.47 % to $1,216.29 million, compared to $1,216.29 a year before.


More Return On Assets Ratios
USPH's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
USPH's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for USPH's Competitors
Subscribers only: Roa for U S Physical Therapy Inc's Suppliers
Subscribers only: Return On Assets for USPH's Customers

You may also want to know
USPH's Roi USPH's Inventory Turnover Ratio USPH's Growth Rates USPH's Dividend Comparisons
USPH's Profitability Ratios USPH's Asset Turnover Ratio USPH's Dividend Growth
USPH's Roe USPH's Valuation Ratios USPH's Financial Strength Ratios USPH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Protagonist Therapeutics inc   11.02 %
Agilent Technologies inc   10.97 %
Prestige Consumer Healthcare Inc   10.90 %
Lemaitre Vascular Inc   10.90 %
Ufp Technologies Inc   10.85 %
Progyny Inc   10.66 %
Regeneron Pharmaceuticals Inc   10.60 %
Johnson and Johnson  10.60 %
Tenet Healthcare Corp  10.49 %
Bristol myers Squibb Company  10.27 %
Solventum Corporation  10.13 %
Globus Medical Inc   10.04 %
Universal Health Services Inc   9.92 %
Entrada Therapeutics Inc   9.51 %
Amgen Inc   9.48 %
National Healthcare Corp  9.28 %
Tactile Systems Technology Inc   9.17 %
Bioventus Inc   9.08 %
Infusystem Holdings Inc  8.63 %
Penumbra Inc  8.63 %
Utah Medical Products Inc  8.50 %
Boston Scientific Corporation  8.34 %
3m Company  8.27 %
Jazz Pharmaceuticals Plc  8.19 %
Pediatrix Medical Group Inc   8.09 %
Veracyte Inc   8.04 %
Stryker Corp  7.89 %
Lifevantage Corp  7.87 %
Embecta Corp   7.82 %
Beone Medicines Ltd   7.82 %


Date modified: 2026-09-05T07:02:12+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.